http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03223251-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 1990-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68b9bc89a8739f17852808c122908325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e7e45de4deb604a7a11ca4caf2a1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b28e1bd1e8fce6be24c1353f429b9e4
publicationDate 1991-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03223251-A
titleOfInvention Aminonaphthalene compound
abstract NEW MATERIAL:An aminonaphthalene compound expressed by formula I [B is 5-7 membered aza heterocyclic group; A is direct bond, hydrocarbon residue, oxo, hydroxyimino, divalent or trivalent aliphatic hydrocarbon residue; full line and dotted line each represent single bond and double bond (provided that when A represents direct bond, it is single bond); R 2 and R 3 are H or hydrocarbon residue and R 1 and R 2 form cyclic amino together with adjacent N; (p) is 1 or 2] and slat thereof. n EXAMPLE: 1-Acetyl-4-[(4-dimethylamino-1-naphthyl)carbonyl]piperidine. n USE: Cerebral edema treating agent, brain nerve cell protecting agent, cholin esterase inhibiting agent and brain function improving agent. n PREPARATION: A compound expressed by formula II (R 7 is acyl, etc.; X is halogen; (m) is 0-2) is subjected to a reaction with a compound expressed by formula III (Y is halogen) and then made to react with a compound expressed by formula IV to provide the compound expressed by formula V which is one of the compound expressed by formula I. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1891954-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0607864-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0607864-A3
priorityDate 1989-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67923893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235135705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803

Total number of triples: 33.